搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
14 天
Oruka Therapeutics股价因H.C. Wainwright看好其银屑病治疗前景而获买入评级
周一,H.C. Wainwright对Oruka Therapeutics (NASDAQ:ORKA)给予积极展望,该公司以买入评级和12个月目标价每股45美元对这家生物科技公司启动了覆盖。这一评级得到支持的原因是该公司正在开发用于炎症和免疫学(I&I)领域的下一代生物制剂。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Liberty win first WNBA title
The Vessel to reopen
Oscar makes landfall
AR marijuana votes blocked
Arizona official pleads guilty
Gold hits fresh high
Ex-Iron Maiden singer dies
Helicopter hits radio tower
Advance to World Series
$1 million daily giveaway
NYC subway death trial
Hezbollah assets targeted
To roll out AI agents in Nov
American activist Wair dies
SCOTUS rejects Cohen suit
New Mexico flash flooding
GA county to sue BioLab
Faces new lawsuits
Judge weighs Louisiana law
Minks released, 2 arrested
SCOTUS rejects bid
Anti-missile system in Israel
Had multiple drugs in body?
Out with ruptured Achilles
Bitcoin nears $70,000
Files suit over fake drugs
Sued by Murdoch’s firms
NC tops 1 million votes
To get up to $325M grant
Stroke prevention guidance
University protest arrests
Tours Helene storm damage
Urges support for Ukraine
反馈